Background: 9-cis-Retinoic acid (9-cis-RA) and N-(4-hydroxyphenyl)retinamide (4-HPR) are effective chemopreventive agents against epithelial tumors in the oral cavity, breast, and prostate. We tested the inhibitory activity of these retinoids against N-nitrosomethylbenzylamine (NMBA)-induced tumorigenesis in the rat esophagus. Methods: Male Fischer 344 rats were randomly assigned to receive diets either lacking or containing 9-cis-RA or 4-HPR for 1 week before tumor initiation with NMBA and then for the duration of the study. NMBA metabolism, O 6 -methylguanine adduct formation, and cytochrome P450 messenger RNA (mRNA) expression in the esophagi of the rats were studied to investigate the mechanisms by which dietary 4-HPR affects tumorigenesis. All statistical tests were two-sided. 
Esophageal cancer is currently the seventh most common cancer in both men and women worldwide (1, 2) . The incidence rates for esophageal cancer are highest in China, Central Asia, India, Iran, Puerto Rico, France, and the Transkei region of South Africa (3) (4) (5) . Major risk factors for this cancer include smoking, alcohol consumption, and the consumption of saltpickled and moldy foods (5, (6) (7) (8) . Investigations conducted in areas with a high incidence of esophageal cancer, where squamous cell carcinoma (SCC) represents the predominant histologic type (9) , suggest that N-nitroso compounds and their precursors may be etiologic factors (3, 4) . Because current therapies have not effectively improved the survival rates among patients with cancers of the esophagus, primary chemoprevention may serve as a viable alternative for the control of this cancer.
Nitrosamine-induced tumorigenesis in the rat esophagus is a valuable animal model for human esophageal SCC. Among several asymmetric dialkylnitrosamines that induce tumors in this animal model, N-nitrosomethylbenzylamine (NMBA) is the most potent (10, 11) . After subcutaneous injection of NMBA, esophageal tumors form within 15-20 weeks. Most of these tumors are squamous cell papillomas. A number of readily discernible preneoplastic lesions are also produced, including simple hyperplasia, leukoplakia, and dysplastic lesions (10, 12, 13) . The rat model of NMBA-induced esophageal tumorigenesis has been found to be a valuable tool both for understanding the biology of this disease and for assessing the chemopreventive activity of several compounds, including diallyl sulfide (11) , ellagic acid (12) , green and black teas (14) , and isothiocyanates (15) .
During the past decade, the efficacy of retinoids as chemopreventive agents has been examined in numerous in vivo and in vitro model systems. For example, both synthetic and natural analogues of vitamin A are effective in suppressing tumor development in models of skin, breast, oral cavity, lung, prostate, bladder, liver, and pancreatic cancers (16) (17) (18) (19) . Retinoids are particularly effective chemopreventive agents for tumors of epithelial origin, such as those that arise in the aerodigestive tract (19) . For example, 13-cis-retinoic acid (13-cis-RA) inhibits or delays 7,12-dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis in the buccal pouch and tongue of hamsters and 4-nitroquinoline-1-oxide-induced oral SCCs in mice (20, 21) . Similarly, vitamin A and N-(4-hydroxyphenyl)retinamide (4-HPR) can reverse premalignant lesions and can inhibit the development of adenomas and adenocarcinomas in animal models of lung cancer (18, 22, 23) . Based on these preclinical studies, several retinoids, including 13-cis-RA and 4-HPR, are being tested in clinical trials of epithelial cancers in humans [reviewed in (19) ].
Investigations into the molecular mechanisms of retinoid action in aerodigestive cancers (24) have shown that these agents affect cell growth and apoptosis, cell differentiation, and gene expression. Such studies have also led to the proposal that aerodigestive cancers result from a field cancerization process, whereby the whole tissue field, including the oral cavity, lung, and esophagus, is at risk for tumor development because it is exposed to similar extrinsic and/or intrinsic etiologic factors (24) . Therefore, it is conceivable that retinoids, which are effective inhibitors of carcinogenesis in the oral cavity and lung, may also inhibit the development of esophageal cancers.
The role of retinoids as potential chemoprevention agents in esophageal cancers has not been fully studied. We have evaluated the efficacy of two retinoids, 9-cis-retinoic acid (9-cis-RA), a naturally occurring retinoid, and 4-HPR, a synthetic amide of all-trans-RA, as inhibitors of NMBA-induced esophageal tumorigenesis in the Fischer 344 rat.
MATERIALS AND METHODS

Animals
Male Fischer 344 rats (5-6 weeks old) were purchased from Harlan SpragueDawley (Indianapolis, IN). They were housed three per cage at 20°C ± 2°C ambient temperature, at 50% ± 10% relative humidity, and in a 12-hour light/ dark cycle. Because retinoids are light sensitive, yellow lights were used in the rooms where the animals were housed for the duration of the experiments. Cages were changed twice a week to provide hygienic conditions. The rats were maintained on a modified AIN (American Institute of Nutrition)-76A diet containing 20% casein, 0.3% DL-methionine, 52% cornstarch, 13% dextrose, 5% cellulose, 3.5% AIN salt mixture, 1% AIN vitamin mixture, and 0.2% choline bitartrate (Dyets Inc., Bethlehem, PA). Neobee M-5 oil (Stepan Co., Northfield, IL) was added at 5% (wt/wt) to the AIN-76A diet by mixing in a Hobart mixer (Hobart Corp., Grove City, OH) for 20-30 minutes. Food and water were provided ad libitum. Animal care was in accordance with the guidelines of the Animal Care and Use Committee of The Ohio State University, Columbus. Measurements of body weight and food consumption were recorded weekly for the duration of the studies.
Chemicals
NMBA was obtained from Ash Stevens (Detroit, MI) and was greater than 98% pure when analyzed by reverse-phase high-performance liquid chromatography (HPLC). Tritiated NMBA [ 3 H]NMBA, provided by Dr. Lisa A. Peterson (University of Minnesota Cancer Center, Minneapolis), was greater than 97% pure when analyzed by HPLC and had a specific activity of 2.477 Ci/mmol. 4-HPR and 9-cis-RA were obtained from the Division of Cancer Prevention and Control Repository, National Cancer Institute (Rockville, MD). HPLC-grade acetonitrile and other laboratory reagents were purchased from Fisher Scientific (Pittsburgh, PA).
Diet Preparation
Retinoid-containing diets were freshly prepared every 2 weeks. The unused portions of the diets were stored in black bags at −20°C and were discarded when fresh diets were prepared. 9-cis-RA and 4-HPR were weighed in the dark on an analytic balance to provide the quantities required for the preparation of the various diets. The low-and high-9-cis-RA diets contained 0.06 g and 0.12 g 9-cis-RA/kg AIN-76A diet, respectively. The diets with the low and high concentrations of 4-HPR contained 0.4 g and 0.8 g 4-HPR/kg AIN-76A, respectively. The required amount of 9-cis-RA for each diet was dissolved initially in 5 mL of ethanol, and that solution was mixed with the Neobee M-5 oil portion of the diet. That mixture was then added to the AIN-76A diet by mixing in a Hobart mixer for 20-30 minutes. 4-HPR was added as a dry ingredient to the AIN-76A diet. The diet in each cage was replaced three times during each 2-week period, on Monday and Friday of the first week and on Wednesday of the second week. Previous analyses in our laboratory, as well as other published reports (25, 26) , have found that 9-cis-RA and 4-HPR are stable in the diet when they are stored and dispensed in this manner.
Rat Esophageal Tumor Bioassays
We performed two bioassays to evaluate the efficacy of retinoids as inhibitors of NMBA-induced esophageal tumorigenesis. In the first bioassay, groups of six rats each were randomly assigned to receive either the modified AIN-76A diet or the modified AIN-76A diet containing either low or high concentrations of 9-cis-RA or 4-HPR. One group of rats, which was randomly assigned to receive the modified AIN-76A diet and NMBA injections, contained three additional animals. One week after the initiation of the respective diets, one group of rats on each type of diet began to receive NMBA (0.5 mg/kg body weight) in 20% dimethyl sulfoxide (DMSO) or 20% DMSO only (vehicle) by subcutaneous injection thrice weekly for 5 weeks. At 15 weeks after the NMBA injections were initiated, the animals were killed by CO 2 asphyxiation and subjected to gross necropsy. Their esophagi were removed, opened longitudinally, and examined for the presence of tumors. Tumors measuring greater than or equal to 0.5 mm in length, width, and depth were counted and recorded in a blinded fashion.
In the second bioassay, only the effects of 4-HPR were evaluated. Groups of 25 rats were randomly assigned to receive either the modified AIN-76A diet or the modified AIN-76A diet containing either low or high concentrations of 4-HPR. Two groups of rats, one on the modified AIN-76A diet and the other on the modified AIN-76A diet containing the high concentration of 4-HPR, had three additional animals. One week after the initiation of the respective diets, one group of rats on each type of diet began to receive NMBA (0.5 mg/kg body weight) in 20% DMSO or 20% DMSO only (vehicle) by subcutaneous injection thrice weekly for 5 weeks. At 15 weeks after the NMBA injections were initiated, three rats each from the NMBA-alone and NMBA-plus-0.8-g/kg 4-HPR diet groups were killed to provide a preliminary assessment of tumor induction in response to NMBA. The bioassay was terminated at 20 weeks after initiation of NMBA or vehicle injections. At that time, the esophagus from each animal was removed and examined for tumors. Tumors were measured, counted, and recorded as described for the first bioassay.
In Vitro Assay for NMBA Metabolism
Groups of three animals were randomly assigned to receive either the modified AIN-76A diet or the modified AIN-76A diet containing 9-cis-RA or 4-HPR at low or high concentrations. The animals received their respective diets for 1 week, after which they were killed and their esophagi were aseptically removed and immersed in Leibowitz's L-15 medium (Life Technologies, Inc. [GIBO BRL], Rockville, MD). Individual esophagi were opened longitudinally under sterile conditions, divided into halves, and placed mucosal side up in 60-mm tissue culture dishes containing 3 mL of PFMR-4 culture medium (BRFF, Ijamsville, MD) supplemented with epidermal growth factor, hydrocortisone, insulin (Sigma Chemical Co., St. Louis, MO), dialyzed fetal bovine serum (Life Technologies, Inc.), and 1 M [ 3 H]NMBA. These explants were then placed in an incubation chamber under 50% oxygen and maintained at 37°C with a gentle rocking motion to bathe the cultures in media (15) . After 4 hours of incubation, 250-L aliquots of media were collected from each explant culture, filtered through Acrodiscs (0.2-M pore size; Gilman Sciences, Ann Arbor, MI), and analyzed by reverse-phase HPLC. The HPLC system used for these analyses consisted of a gradient controller, two 510 pumps, a C18 column, a 484 UV detector, an Eppendorf column heater (all from Millipore Corp., Bedford, MA), and a ␤-Ram radioflow detector (IN/US Systems Inc., Tampa, FL). Fifty microliters of each sample of filtered medium was analyzed, along with authentic standards for NMBA, benzyl alcohol, benzaldehyde, and benzoic acid. Samples were eluted with 2.4% acetic acid (pH 3.7) in 20% acetonitrile. The eluent flow rate was 1.5 mL/minute. The scintillation cocktail flow rate through the radioflow detector was 3.0 mL/minute. Detection of eluates was by UV absorption at 254 nm and flow-through radioactivity. Major peaks of radioactivity were tagged, and the area under each peak was expressed as a percent of total radioactivity in the 50-L sample (27) . The results from three independent explant culture experiments were averaged.
DNA Adduct Study
To evaluate the effects of dietary administration of 4-HPR on NMBA-induced formation of O 6 -methylguanine (O 6 -meGua) adducts in the rat esophagus, we randomly assigned groups of 18 animals each to receive either the modified AIN-76A diet (two groups) or the modified AIN-76A diet containing either low or high 4-HPR concentrations (one group each). With the exception of one group of rats on the modified AIN-76A diet alone, all rats received a single dose of NMBA, at 0.5 mg/kg body weight, in 20% DMSO, which was administered by subcutaneous injection 1 week after initiation of the respective diets. Animals in the vehicle control group were fed the modified AIN-76A diet and received a single injection of 20% DMSO. Nine animals from each group were killed by CO 2 asphyxiation at both 24 and 48 hours after injection. The esophagus from each animal was excised and opened longitudinally, and the epithelium was separated from the underlying tissues and immediately frozen in liquid nitrogen and stored at -80°C. Three randomly selected esophageal mucosae from each group of rats were pooled to yield a single sample for the analysis of O 6 -meGua adducts. Thus, for each treatment group, three samples were tested for each of the two time points. Genomic DNA was isolated from each sample according to protocols published previously (28, 29) . Seventy-five micrograms of purified DNA was subjected to acid hydrolysis at 80°C for 45 minutes and analyzed by strong cation exchange HPLC coupled with fluorescence detection as described previously to detect O 6 -meGua (30) . Levels of O 6 -meGua were normalized to the overall guanine content of each sample.
Cytochrome P450 Messenger RNA Expression Study
Groups of four animals each were randomly assigned to receive either the modified AIN-76A diet or the modified AIN-76A diet containing either low or high 4-HPR concentrations. The animals were killed by CO 2 asphyxiation after 1 week on their respective diets. The esophagus was removed from each animal, and the mucosa was stripped and frozen immediately in liquid nitrogen. Total RNA was extracted from each esophageal mucosa with the use of the TRIzol reagent (Life Technologies, Inc.) according to the manufacturer's instructions. We confirmed the integrity of the RNA samples by resolving 1 g of total RNA on an agarose gel and visualizing the 18S and 28S ribosomal RNA bands after the gel was stained with ethidium bromide. The messenger RNA (mRNA) levels for CYP2A3, CYP2E1, and hypoxanthine-guanine phosphoribosyltransferase (HPRT) in each mucosal RNA sample were determined by semiquantitative reverse transcription (RT)-polymerase chain reaction (PCR) as described previously with modifications (31). CYP2A3 and CYP2E1 expression was normalized against that of the housekeeping gene HPRT in each RNA sample. The sequences of the oligonucleotide primer pairs used for PCR were 5Ј-TCGAGGAGCGTATCCAAGAG-3Ј (sense) and 5Ј-GATGAGGAAAGAGTC-GATGA-3Ј (antisense) for CYP2A3; 5Ј-TGGCATCACCATTGCCTTGC-3Ј (sense) and 5Ј-GAATTGCGCCTCCCTTTGGA-3Ј (antisense) for CYP2E1; and 5Ј-GGGCTATAAGTTCTTTGCTGAC-3Ј (sense) and 5Ј-CAAACAT-GATTCAAATCCCTGC-3Ј (antisense) for HPRT. RT was performed on 2 g of each RNA sample in a 20-L reaction with the use of 100 pmol of random hexamers and 2.5 U of Superscript II™ reverse transcriptase (Life Technologies, Inc.). Then 2.5 L of the RT reaction mixture was used as a template for 25-L PCR reactions. The conditions for PCR were optimized for each gene-specific primer set. All PCR experiments began with an initial denaturation at 95°C for 30 seconds. The subsequent cycling conditions were as follows: 95°C for 15 seconds, 56°C for 30 seconds, and 72°C for 30 seconds, for 34 cycles for CYP2A3; 95°C for 15 seconds, 60°C for 30 seconds, and 72°C for 30 seconds, for 34 cycles for CYP2E1; and 95°C for 15 seconds, 60°C for 30 seconds, and 72°C for 30 seconds, for 27 cycles for HPRT. All PCR experiments underwent a final extension cycle at 72°C for 7 minutes. The amplified products were separated on a 1.8% agarose gel, stained with ethidium bromide, and analyzed with the use of an IS-1000 Digital Imaging System (Alpha Innotech Corp., San Leandro, CA). The peak intensities for individual gel bands were quantitated, and those values were used to estimate the amounts of CYP2A3 or CYP2E1 mRNAs relative to the amount of HPRT mRNA in each sample. The RT-PCR reactions were repeated three times with the use of RNAs isolated in two separate experiments.
Statistical Analysis
Data were analyzed for statistical significance, defined as ␣ഛ.05, with the use of analysis of variance (ANOVA) followed by the Newman-Keuls multiplecomparisons test. Whenever the group means were statistically significantly different, 95% confidence intervals (CIs) were constructed for the difference between the means. It was assumed that the variance of two groups was unequal. Satterthwaites's method was used for the calculation of the degrees of freedom for t distribution. Since the tumor sizes were not normally distributed, KruskalWallis one-way ANOVA on ranks test followed by Kruskal-Wallis multiplecomparisons Z-value test were used for their analyses. Differences in the number of tumors larger than 0.5 mm in all dimensions in various treatment groups were analyzed by a chi-squared test. The proportion (p) of tumors larger than 0.5 mm in all dimensions has binomial distribution with variance p (1 -p) . Since the sample size, n, was large enough to satisfy np(1 -p)ജ10, normal approximation was used for the calculation of 95% CIs. All P values were two-sided.
RESULTS
Tumor Bioassays
In the first bioassay, we evaluated the chemopreventive activities of the natural retinoid, 9-cis-RA, and the synthetic amide of all-trans-RA, 4-HPR, against NMBA-induced tumorigenesis in the rat esophagus. These two retinoids were chosen because they have been effective chemopreventive agents against other epithelial tumors, such as those arising in the mammary gland, prostate, oral cavity, and skin (32) . The esophageal tumor incidence and multiplicity data from this bioassay are summarized in Table 1 . Dietary administration of 9-cis-RA or 4-HPR did not adversely affect the survival, growth, or food consumption of any of the rats during the 15 weeks of the study (data not shown). Rats that were given injections of vehicle only while on the control diet (group 1) or the test diets containing 9-cis-RA (groups 2 and 3) or 4-HPR (groups 4 and 5) developed no esophageal tumors (Table 1 ). In contrast, rats that were given injections of NMBA while on the control diet (group 6) had a mean tumor multiplicity of 4.1 tumors (95% CI ‫ס‬ 2.9 to 5.3 tumors) per rat. Rats that were given injections of NMBA while on the diets containing low concentrations (group 7) or high concentrations (group 8) of 9-cis-RA did not have statistically significantly different tumor multiplicities compared with rats that were given injections of NMBA and fed the control diet. However, rats that were given injections of NMBA while on diets containing either low (group 9) or high (group 10) 4-HPR concentrations had statistically significant increases (P<.05 for each; difference between group 9 and group 6 ‫ס‬ 4.1 tumors [95% CI ‫ס‬ 0.5 to 7.7 tumors]; difference between group 10 and group 6 ‫ס‬ 5.9 tumors [95% CI ‫ס‬ 1.7 to 10.1 tumors]) in their tumor multiplicities compared with rats that were given injections of NMBA and fed the control diet (group 6). This unexpected increase in tumor multiplicity was greater than twofold for rats that received the diet containing the highest concentration of 4-HPR (10.0 tumors [95% CI ‫ס‬ 6.8 to 13.2 tumors]) compared with rats that received the control diet (4.1 tumors [95% CI ‫ס‬ 2.9 to 5.3 tumors]). We did not observe a dose 
On the basis of these preliminary observations, we performed a second bioassay to further evaluate the effects of 4-HPR on NMBA-induced esophageal tumorigenesis. For this bioassay, 15 animals were randomly assigned to receive vehicle injections while on the control diet (group 1), and 25 animals were randomly assigned to each of the remaining treatment groups consisting of vehicle or NMBA injections and control or test diets (groups 2-6). Six additional animals were randomly assigned to receive NMBA injections; three of those animals were fed the control diet (group 4), and the other three were fed a diet containing the high concentration of 4-HPR (group 6). Those six animals were killed at 15 weeks after the initiation of NMBA injections, and their esophagi were examined to provide a preliminary assessment of tumor response. Whereas the three animals that received dietary 4-HPR had multiple measurable tumors in their esophagi, the three animals that received the control diet had very small esophageal nodules, most of which were less than 0.5 mm in all three dimensions.
Because the tumors in the NMBA-alone group were too small to measure at this point, we decided to maintain the remaining animals on their respective treatments for an additional 5 weeks, thereby continuing the study for a total of 20 weeks after the initiation of NMBA or vehicle injections. As we observed in the first bioassay, dietary 4-HPR had no adverse impact on the growth or on the food consumption of animals in any of the treatment groups studied in the second bioassay (data not shown). Tumor incidence and multiplicity data from this bioassay, which are summarized in Table 2 , exclude data from the six animals killed at 15 weeks. Animals that received NMBA injections while on diets containing low (group 5) or high (group 6) concentrations of 4-HPR had statistically significant increases (P<.05 for each; difference between group 5 and group 4 ‫ס‬ 4.7 tumors [95% CI ‫ס‬ 4.0 to 5.4 tumors]; difference between group 6 and group 4 ‫ס‬ 6.7 tumors [95% CI ‫ס‬ 5.6 to 7.8 tumors]) in their tumor multiplicity compared with rats that were given NMBA injections and fed the control diet (group 4). This increase in tumor multiplicity following 4-HPR administration was dose dependent and was greater than 3.5-fold for rats that received the diet containing high concentrations of 4-HPR (0.
In the second bioassay, we also evaluated the effects of dietary 4-HPR on the average tumor size among animals that received NMBA injections (Table 3) . We observed a wide variation in individual tumor size within a treatment group and did not observe an association among tumor sizes within an animal. We, therefore, used tumor as the unit of analysis for these data. A total of 63 tumors with an average size of 6.86 mm 3 (95% CI ‫ס‬ 4.8 to 8.82 mm 3 ) were recorded and measured in the esophagi of animals that were given injections of NMBA while on the control diet (group 4). By comparison, animals that were given injections of NMBA and fed diets containing low and high concentrations of 4 33 .3%]) compared with the percentage of tumors that measured larger than 0.5 mm in all dimensions in animals that received NMBA while on the control diet (group 4). Thus, compared with rats fed a control diet, rats exposed to dietary 4-HPR before, during, and after injection of NMBA had statistically significant increases in both the number and the size of tumors in their esophagi.
NMBA Metabolism Study
We next investigated the potential mechanisms through which dietary 4-HPR enhanced NMBA-induced tumorigenesis in the rat esophagus. Because the rats in the two bioassays were exposed to dietary 4-HPR for the entire study period, we hy- pothesized that a component of the enhanced tumorigenicity might reside in the initiation stage of esophageal tumorigenesis. For example, 4-HPR might enhance NMBA metabolism in esophageal tissues, potentially increasing the number of initiated cells and, therefore, contributing to enhanced tumor multiplicity in animals fed 4-HPR.
Using [ 3 H]NMBA, we therefore compared the abilities of esophageal explants derived from animals fed the control diet or the test diets containing 4-HPR to metabolize NMBA in vitro. We analyzed [ 3 H]NMBA metabolism in the explants after 4 hours of incubation because we observed in preliminary experiments that approximately 50% of [ 3 H]NMBA was metabolized in explants from animals fed the control diet at that time point and that adequate levels of NMBA metabolites were detected in the aliquots of media collected from these explants ( Table 4) . Under the incubation conditions used in our experiment, [ 3 H]NMBA remained stable for up to 24 hours in the culture media in the absence of esophageal tissues (data not shown).
Using HPLC, we detected three major unidentified peaks of radioactivity (i.e., metabolite peaks 1, 2, and 3) in media aliquots collected from all explants after 4 hours of incubation with [ 3 H]NMBA. We also detected radioactive peaks that co-eluted with two known metabolites of NMBA, benzyl alcohol and benzoic acid, as well as unmetabolized NMBA, as was expected on the basis of a previous report (28) . The amount of peak 1 in media aliquots collected from esophageal explants from animals fed diets containing either low (group 2) or high (group 3) concentrations of 4-HPR was statistically significantly increased (P<.05 for each; difference between group 2 and group 1 ‫ס‬ 4.9% [95% CI ‫ס‬ 1.6% to 8.2%]; difference between group 3 and group 1 ‫ס‬ 7.3% [95% CI ‫ס‬ 4.4% to 10.2%]) compared with the amount of peak 1 in media aliquots from explants established from animals fed the control diet (group 1). A statistically significant increase in the amount of peak 2 was also seen in the animals fed the diets containing low (group 2) and high (group 3) concentrations of 4-HPR (P<.05 for each; difference between group 2 and group 1 ‫ס‬ 5.9% [95% CI ‫ס‬ 3.7% to 8.1%]; difference between group 3 and group 1 ‫ס‬ 8.8% [95% CI ‫ס‬ 4.5% to 13.1%]) compared with media aliquots from explant cultures of esophagi from animals fed the control diet (group 1). This finding represented a near twofold increase in peak 2 metabolite present in media from the group fed the diet with a high concentration of 4-HPR (18.0% [95% CI ‫ס‬ 13.1% to 22.1%]) compared with media from explant cultures from the group fed the control diet (9.2% [95% CI ‫ס‬ 8.8% to 9.6%]). Media from animals fed the high dietary concentration of 4-HPR also contained more benzoic acid, the final product of NMBA metabolism, than media aliquots from animals fed the control diet (Table 4 53 .3%]). Benzaldehyde was not detected in any of the media aliquots, perhaps because it was rapidly converted to benzoic acid by both enzymatic and nonenzymatic means (27) . Taken together, these data suggest that dietary administration of 4-HPR increases the metabolism of NMBA in the rat esophagus. This effect of 4-HPR on NMBA metabolism was not dose related. In contrast, esophageal explants from animals fed 9-cis-RA did not differ in their ability to metabolize NMBA compared with explants from animals fed the control diet (Table 4) .
DNA Adduct Study
Metabolic activation of NMBA by esophageal cytochrome P450 (CYP) enzyme(s) generates electrophilic species and results in the methylation of DNA at the N 7 and O 6 positions of guanine (33, 34) . The O 6 -meGua adduct has been implicated in the generation of NMBA-induced mutations and, therefore, has been associated with its carcinogenic effects (35) . We measured levels of O 6 -meGua in the genomic DNA isolated from esophagi of animals that had received a single dose of NMBA while on the control diet or both 4-HPR-containing diets. These results are shown in Table 5 . At 24 hours after NMBA dosing, rats fed the diets containing the low concentration of 4-HPR (group 2) or the high concentration of 4-HPR (group 3) had statistically significantly increases (P<.05 for each; difference -meGua/mol guanine [95% CI ‫ס‬ 11.5 to 16.7 pmol O 6 -meGua/mol guanine]). In summary, the results from the metabolism and DNA methylation studies demonstrate that dietary 4-HPR enhances NMBA metabolism and increases the levels of O 6 -meGua, a mutagenic adduct, in rat esophageal DNA.
CYP Expression Study
The exact identity of the CYP enzyme(s) involved in NMBA metabolism in the rat esophagus is not known. Previous studies (36, 37) have suggested that two CYPs, CYP2A3 and CYP2E1, can metabolize NMBA in vitro, which makes them candidate enzymes for the in vivo metabolism of NMBA in the rat esophagus. Using semiquantitative RT-PCR, we examined the effects of dietary 4-HPR on the steady-state mRNA levels of these two CYPs in the rat esophagus. We found that CYP2A3 mRNA levels in esophagi were consistently higher in animals that had received 4-HPR in their diet for 1 week than in animals that had received the control diet (Fig. 1) . The mean increase in CYP2A3 mRNA was 4.2-fold (95% CI ‫ס‬ 2.5-fold to 5.9-fold) among three experiments after normalization to the mRNA levels for the housekeeping gene HPRT. We observed no statistically significant differences in CYP2A3 mRNA levels between animals fed low or high concentrations of dietary 4-HPR, nor were any consistent alterations in CYP2E1 mRNA levels found among the different treatment groups in these studies.
DISCUSSION
We have examined the efficacy of 9-cis-RA and 4-HPR for their chemopreventive activity against NMBA-induced rat esophageal tumorigenesis when each was given in a complete carcinogenesis protocol. Unlike other studies, which have documented the antitumor effects of 4-HPR in animal models, we observed that dietary administration of 4-HPR produced a statistically significant enhancement in tumor response to NMBA in the rat esophagus. A potential explanation for our results may lie in the target specificity of retinoids [reviewed in (38) ]. For example, 13-cis-RA prevents two-stage carcinogenesis in mouse skin as well as chemically induced cancers of the bladder in mice. However, 13-cis-RA is not effective against DMBAinduced or N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis in rats. Similarly, although 4-HPR is highly effective against mammary and urinary bladder carcinogenesis, it is not effective against carcinogenesis in the colon. This tissue specificity may reflect different tissue distributions of these ret- Dietary N-(4-hydroxyphenyl) retinamide (4-HPR) increases esophageal CYP2A3 messenger RNA (mRNA) levels. Total RNA was isolated from the esophageal mucosae of animals maintained for 1 week on diets lacking (control) or containing low (0.4 g/kg) or high (0.8 g/kg) concentrations of 4-HPR and was analyzed for the expression of CYP2A3 and CYP2E1 by reverse transcription (RT)-polymerase chain reaction (PCR) analysis. PCR products (10 L of each) were resolved on a 1.8% agarose gel, stained with ethidium bromide, and visualized and quantitated with the use of a digital imaging system as described in the "Materials and Methods" section. Individual band intensities were normalized to those obtained by amplification of the messenger RNA for hypoxanthineguanine phosphoribosyltransferase (HPRT) within the same RNA sample. A representative gel image from one of three independent experiments is shown. After normalizing to the mRNA levels for HPRT, the mean increase in CYP2A3 mRNA ranged from 2.5-fold to 5.9-fold among three experiments. Each lane contains the RNA from an individual animal in the various treatment groups. The negative controls for the RT reactions (lanes labeled Neg RT Con) were performed in the absence of reverse transcriptase. MW ‫ס‬ molecular weight markers. †Mean values, with 95% CIs, from three independent samples, each of which was derived from a pool of three esophagi.
‡Statistically significantly different from group 1 (P<.05), as determined by analysis of variance followed by Newman-Keuls multiple-comparisons test.
§Statistically significantly different from group 1 and group 2 (P<.05), as determined by analysis of variance followed by Newman-Keuls multiplecomparisons test.
inoids and/or differences in their metabolism in different organs. For example, when administered orally to rodents, 4-HPR is extensively metabolized to yield the primary metabolite 4-methoxyphenylretinamide, which is more lipophilic than the parent compound. Because of the high lipophilicity of its metabolites, 4-HPR has a substantially long half-life of 12 hours. Although 4-HPR accumulates primarily in the bladder, liver, and mammary glands (39, 40) , our results suggest that 4-HPR may also accumulate in the rat esophagus and can substantially affect tumorigenesis in response to NMBA at this organ site.
Retinoids have been shown to mediate the inhibition as well as the enhancement of chemical carcinogenesis in animal models. For example, Crist et al. (41) found that 4-HPR inhibits the initiation phase of MNU-induced mammary carcinogenesis in rats. In contrast, Grubbs et al. (42) reported a trend toward an increase in the number of mammary cancers when either 4-HPR or retinyl acetate was administered 2 months before MNU treatment. Pretreatment with these retinoids also increased the incidence of benign tumors in DMBA-treated rats without affecting the development of adenocarcinoma. However, other studies of DMBA-and MNU-induced mammary carcinogenesis in the same animal models (33, 43, 44) have shown that, when given after carcinogen exposure, retinyl acetate and 4-HPR effectively reduce tumor incidence and multiplicity and act as potent antipromotion/progression agents. A similar situation exists in mouse skin models: Whereas most retinoids inhibit tumor promotion by phorbol esters in a two-stage carcinogenesis protocol (45) , retinoic acid failed to prevent DMBA-induced carcinogenesis in the skin when used in a complete carcinogenesis protocol. In some experiments, retinoic acid actually increased the number of papillomas per mouse (46) . Similarly, retinoic acid enhanced tumor response when UV irradiation was used as a complete carcinogen (47, 48) .When given before and during carcinogen exposure, 4-HPR has also been found to enhance the incidence of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung adenomas in A/J mice (49) . Taken together with the results from our study, these findings suggest that the timing of retinoid administration may be an important determinant of its effects on carcinogenesis. When given before or simultaneously with the carcinogen, these retinoids can substantially enhance tumor formation in the very same target tissues in which they inhibit tumor formation when given subsequent to tumor initiation with the carcinogen. It may, therefore, be necessary to evaluate all retinoids for their effects on both tumor initiation and tumor promotion in preclinical settings before beginning clinical chemoprevention trials.
We also investigated the potential mechanisms through which 4-HPR affects NMBA-induced esophageal tumorigenesis. For NMBA to be carcinogenic, it must be metabolized to produce electrophilic species that can react with DNA. CYP enzymes in the rat esophageal epithelium catalyze the ␣-hydroxylation of NMBA as a part of this process. Hydroxylation of the methylene carbon of NMBA, in particular, produces the ␣-hydroxyderivative 1, which spontaneously decomposes to benzaldehyde and the electrophile, methanediazohydroxide. Methanediazohydroxide methylates DNA at the N 7 and O 6 positions of guanine [reviewed in (33) ]. In our study, dietary 4-HPR increased the metabolic activation of NMBA in the rat esophagus, and this increased metabolism was associated with an increase in O 6 -meGua adducts in esophageal DNA. Although the specific CYP enzymes involved in NMBA metabolism in the rat esophagus are not known, our preliminary evidence indicates that dietary 4-HPR also increases the steady-state levels of CYP2A3 mRNA. To our knowledge, this is the first report describing the effects of 4-HPR on carcinogen metabolism in an animal model. We suggest that the increased metabolism of NMBA and the subsequent elevations in methylated DNA adducts that result from dietary 4-HPR exposure could cause more frequent genetic mutational events. These events could lead ultimately to a higher number of initiated cells that, in part, would contribute to increased tumor formation.
Our observation that animals fed 4-HPR have statistically significantly larger tumors than animals fed the control diets points to the additional effects of 4-HPR during the promotion and progression phases of carcinogenesis. Luo et al. (50) found that dietary 4-HPR induced extensive cellular proliferation in the esophagi of treated animals. In addition, generation of reactive oxygen species has been found to be an important mechanism of 4-HPR effects in human cervical cancer (51), head and neck cancers (52) , and lung cancer cell lines (49) . Increased levels of reactive oxygen species have been shown to facilitate tumor promotion and progression (53) (54) (55) . We postulate that similar mechanisms may contribute to the increased tumor size in animals fed 4-HPR.
It is premature to assess the implications of our findings with respect to the clinical use of 4-HPR. It was reported recently that oral administration of 4-HPR had no effect on squamous metaplasia or dysplasia in the bronchial epithelium of current smokers (56) . However, it is not known if these individuals had any esophageal pathologic condition, such as premalignant lesions, that was affected by 4-HPR administration. Similarly, no increase in the incidence of tumors at other sites was noted in a study in which more than 2500 women with breast cancer were randomly assigned to receive either 4-HPR or no treatment (57) . However, this cohort may not be the most appropriate one in which to detect the tumor-enhancing effects of 4-HPR because these subjects were not at high risk for esophageal cancer. It is likely that the paradoxical effects of 4-HPR in humans may depend on exposure to certain carcinogens and/or may be limited to specific tissues, as appears to be the case in rodent models of chemical carcinogenesis.
In summary, our data reveal that dietary administration of 4-HPR dramatically enhances tumor response to NMBA in the rat esophagus. In contrast, we found that dietary administration of 9-cis-RA did not statistically significantly alter tumor multiplicity in response to NMBA, although we did observe a trend toward increased tumorigenesis. A larger study will be necessary to fully evaluate the effects of 9-cis-RA on tumor response in this model system. Our mechanistic studies of animals fed 4-HPR indicate that enhancement of initiation events, such as NMBA metabolism and O 6 -meGua adduct formation, is an important part of sensitization to NMBA-induced rat esophageal tumorigenesis. The increased average tumor size in animals fed 4-HPR points to the additional promotional effects of this synthetic retinoid. Taken together with the published studies on the effects of retinoids on rat mammary carcinogenesis, our observations of the rat esophagus suggest that dietary 4-HPR can exert opposing effects on different target organs in the same species. Our findings are potentially important in light of ongoing human clinical studies of 4-HPR for the chemoprevention of breast and prostate cancers. The ability of 4-HPR to enhance tumor initiation may result in a paradoxical effect of this retinoid in other sites, such as the aerodigestive tract, where it can possibly enhance nitrosamine-induced carcinogenesis.
